This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Digital health technology has seen an incredible growth in the last few years, fueled by a combination of consumerization of wearable technologies, ubiquity of mobile devices, proliferation of technology incubators, attention by government health and regulatory agencies and involvement of large companies heretofore not focused on healthcare.
Department of Health and Human Services said it would temporarily extend telemedicine flexibilities for the prescription of certain controlled medications granted under the COVID-19 PublicHealth Emergency, which is set to expire on May 11.
Background On March 1, 2023, DEA, in concert with HHS, issued notices of proposed rulemakings (NPRM) to allow for prescribing of certain controlled medications via telemedicine without an in-person medical evaluation of the patient under circumstances that are consistent with publichealth, safety, and effective controls against diversion.
The most common reason that people with an unmet need for mental health care go without it is that they cannot afford the cost of care, according to a national survey conducted by the Substance Abuse and Mental HealthServicesAdministration.
Funding for the Centers for Medicare and Medicaid Services will increase by $100 million, the National Institutes of Health will receive an additional $2.5 This will help to ensure that telehealth and hospital-at-home programs can continue to provide convenient and accessible medical treatment for patients.
It also requires that the Secretary report to Congress on the state of the SNS, and to issue guidance and hold annual meetings with publichealth officials and stakeholders on how states, territories, and Tribes can access the SNS. Modernizes publichealth data through biosurveillance and infectious disease data collection.
Some concerns and reasons noted by the DEA for extending the telemedicine flexibilities include: Reductions in access to care for patients who may not have an established practitioner-patient relationship; Practitioner backlogs for providing in-person medical evaluations; and Urgent publichealth needs for certain controlled medications.
News In a temporary rule, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental HealthServicesAdministration (SAMHSA) extended telemedicine flexibilities for prescribing controlled medications for six months following the end of the publichealth emergency, through November 11.
On December 2, 2022, the Department of Health and Human Services (“HHS”) Substance Abuse and Mental HealthServicesAdministration (“SAMHSA”) released a proposed rule modifying the Confidentiality of Substance Use Disorder Patient Records regulations at 42 CFR Part 2 (“Part 2”).
Ultimately, accurate billing not only ensures fair compensation for services rendered but also underpins the sustained provision of life-saving MAT interventions, embodying the pivotal role of billing proficiency in advancing publichealth initiatives. Looking to streamline your billing process?
Department of Health and Human Services (HHS) and the Substance Abuse and Mental HealthServicesAdministration (SAMHSA) recently released the long anticipated Final Rule to revise the Confidentiality of Substance Use Disorder (SUD) Patient Records regulations at 42 C.F.R. 2] PublicHealth Authority Disclosure.
On Tuesday May 9, 2023, the Drug Enforcement Administration (“DEA”), jointly with the Substance Abuse and Mental HealthServicesAdministration (“SAMHSA”), announced that it will publish a rule to temporarily extend current telemedicine flexibilities for prescribing controlled substances beyond the termination of the Federal PublicHealth Emergency (..)
Prior to the federal COVID-19 PublicHealth Emergency (PHE), to initiate treatment with buprenorphine at an OTP, a practitioner needed to perform a complete in-person physical evaluation. Background and History of Medicare Telehealth Coverage of SUD Treatment.
Consequently, when the Privacy Rule was published in 2003, it was described by the Department of Health and Human Services (HHS) as “a federal floor of privacy protections” that could be preempted by state law if the state law: provided greater privacy protections or privacy rights, provided for the reporting of publichealth issues, or.
CMS updated the Telehealth Originating Site Facility Fee for CY 2023 and is also implementing a number of policies related to Medicare telehealth services in an effort to smoothly transition from changes made during the PublicHealth Emergency (“PHE”).
Attorney and the Substance Abuse and Mental HealthServicesAdministration. In addition, the NPRM proposes to expressly permit disclosures to publichealth authorities as long as the records are de-identified in accordance with HIPAA standards. While HHS considered an opt-in approach to de-identification (i.e.,
Presently, all practitioners who have a current DEA registration that includes Schedule III authority may prescribe buprenorphine for Opioid Use Disorder in their practice if permitted by applicable state law and the federal Substance Abuse and Mental HealthServicesAdministration (“SAMHSA”) encourages them to do so.
"We serve the same families in our Administration for Children and Families that we serve with Medicare and Medicaid, that we serve in our Substance Abuse and Mental HealthServicesAdministration," said Palm. "We're all the same people who need CDC when we need them, etc.
For example, prescribers of buprenorphine must obtain a waiver from the Substance Abuse and Mental HealthServicesAdministration (SAMHSA) prior to writing prescriptions to treat OUD, and those practitioners who wish to treat more than 30 patients are mandated to undertake training. appeared first on Bill of Health.
health care system, but that are especially present for behavioral health needs like substance use, and are exacerbated by other challenges related to stigma, lack of employment, and fragmented or nonexistent care coordination. This reality reflects structural, policy, and legal misalignments common to the entire U.S.
"Connecting callers to local centers that can share information about their community’s services and resources helps to elevate that quality of care," added Miriam Delphin-Rittmon, the HHS assistant secretary for mental health and substance use and leader of Substance Abuse and Mental HealthServicesAdministration.
The bipartisan Coronavirus Aid, Relief, and Economic Security Act (CARES Act) called for the Part 2 regulations to be more closely aligned with the Health Insurance Portability and Accountability Act (HIPAA) Privacy, Breach Notification, and Enforcement Rules.
The high level summary below of some of the Act’s more notable components that are significant in the healthcare arena is not meant to be an exhaustive list of all health policy changes or provisions included in the Act. The Act extends certain flexibilities for Medicare coverage and payment for telehealth services through December 31, 2024.
Department of Health and Human Services (HHS), through the Substance Abuse and Mental HealthServicesAdministration (SAMHSA), awarded nearly $1.5 What You Should Know: – The U.S billion to support states, tribal lands, and territories’ efforts to address the opioid crisis and support individuals in recovery.
trillion spending package, which consists of all 12 fiscal year (FY) 2023 appropriations bills and funds the federal government through September 30, 2023, provides additional assistance to Ukraine, and makes numerous health care policy changes. Agencies Funding Levels/Description Advanced Research Projects Agency for Health (ARPA-H) $1.5
Strengthening the Centers for Disease Control and Prevention (CDC): The Administration for Strategic Preparedness and Response (ASPR), responsible for national disaster and publichealth emergency response, will transfer to the CDC, reinforcing its core mission to protect Americans from health threats.
In November 2022, OCR and the Substance Abuse and Mental HealthServicesAdministration (SAMHSA) issued a Notice of Proposed Rulemaking (NPRM) which sees both Part 2 and HIPAA changes to better align these regulations. Proposed Part 2 and HIPAA Changes in 2023.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content